Background: Selective digestive decontamination of the digestive tract involves the routine administration of oral, gastric, and intravenous antibiotics to mechanically ventilated children to prevent hospital-acquired infections. It has a strong evidence base in adults, with limited pediatric evidence. Current utilization of this intervention among pediatric physicians in North America is unknown. Methods: An electronic survey administered to pediatric critical care and pediatric infectious disease providers in Canada. Participants were surveyed on current institutional practices, their current knowledge of the evidence base, and perceptions of the risks and benefits of the intervention. Descriptive statistics were utilized. Results: 50 out of 143 (35%) surveyed responded. No hospital in Canada routinely performs SDD and the majority of respondents (74%) have neutral opinions on the subject of SDD. There was concern for increasing antibiotic resistance (43%) and some disagreement with the intravenous component of SDD (46%). The majority of respondents stated a need for pediatric-specific evidence before integrating SDD into their practice, even if further, large adult RCTs were performed. Conclusion: Among surveyed providers, there is little knowledge and no use of selective digestive decontamination for the prevention of hospital-acquired infections. Before interventional studies are performed in pediatric practice, there is a need for study of facilitators, barriers and acceptability of SDD in practice.
Background
Hospital-acquired infections (HAI) remain a major contributor to morbidity and mortality among critically ill children around the world [1] [2] [3] [4] . The costs of these infections are large, and estimated attributable costs per critically ill child are over US$40,000 in the United States [5] . The microbiologic etiology of many of these infections are opportunistic organisms that live in the oropharynx and upper digestive tract, often causing infection-related ventilator-associated complications or bloodstream infections [6, 7] .
Evidence-based recommendations to prevent these infections exist [8, 9] . One intervention that has gained interest is selective decontamination of the digestive tract (SDD). SDD involves the application of topical non-absorbable antibiotics to the oropharynx and stomach with or without a short course of intravenous antibiotics [10, [13] [14] [15] [16] [17] [18] . SDD works by the eradication of carriage of aerobic Gram-negative bacilli and pathogenic fungi whilst maintaining Gram positive and anaerobic carriage. SDD has been extensively studied in adult populations, with a sizable mortality benefit documented among critically ill adults in large randomized trials and meta-analyses, and no evidence of worsening antibiotic resistance [10] [11] [12] [13] [14] . However, the use of these decontamination protocols has been limited, even within adult critical care units, due to concerns among clinicians about driving antibiotic resistance, especially in regions with high prevalence of resistant organisms [15] [16] [17] .
In children, there is limited evidence, mostly generated in Europe, suggesting SDD reduces the incidence of hospital-acquired pneumonia [18] . Determining the baseline knowledge of providers in a jurisdiction that has not traditionally performed SDD is crucial before determining whether further study is warranted in the critically ill child.
Methods

Study setting
Between May and July 2016, a national survey was conducted among Canadian pediatric infectious disease (ID) and critical care physician specialists regarding their knowledge surrounding SDD in critically ill children. Approval for the survey was granted by the research ethics board at BC Children's Hospital and the University of British Columbia (Vancouver, Canada).
Survey design
The survey (see Appendix) consisted of 16 questions regarding SDD, including understanding their current institutional practice, their current knowledge of the evidence base, and perceptions of the risks and benefits of SDD. Further, questions were asked to ascertain issues with performing a trial and in incorporating evidence from data generated in adult patients into pediatric practice. The survey was adapted from a validated instrument used in adults, as part of the SUDDICU program of research [15] . The adapted version was pilot tested for content and face validity, as well as utility, on 5 specialists, with no major changes required to be made to the survey during this process.
Survey administration
The survey was anonymous, confidential and self-administered by clinicians via REDCAP, a web-based survey instrument, [19] through two separate electronic mail-outs. Pediatric infectious diseases specialists were identified through being on-staff at the academic teaching hospitals with PICUs in Canada (n = 57), and pediatric critical care specialists were identified through recent survey lists generated through the Canadian Critical Care Trials Group (n = 115).
Statistical analysis
Analysis was mostly descriptive included reporting summary statistics and graphical displays of the distribution of responses. Univariate statistical tests were performed across groups by years in practice and specialty.
Results
From the 172 individuals on the two electronic lists, 143 email addresses were valid; of these, 50 responded to the survey, for a response rate of 35%. This low response rate was attributed to the summer months, as well as an identified lack of familiarity with the concept of SDD. Of the 50 respondents, 41 identified as critical care physicians, 8 as infectious disease physicians, and 1 as an infection control specialist. The years in practice varied, with 35% having between 5 and 10 years' experience, 25% having between 10 and 20, and 30% having more than 20 years clinical experience. There were individuals representing every PICU in the country responding to the survey.
No respondent reported delivering SDD routinely to critically ill children, with only one individual claiming to deliver SDD in a nonprotocolized fashion. The majority of respondents (64%) claimed to have little knowledge of the evidence base for SDD, and to have a neutral opinion (74%) regarding its use (see Fig. 1 ). Forty six percent of respondents were somewhat or strongly opposed to the intravenous component of SDD and 40% thought that using SDD increased antibiotic resistance. A small number of individuals felt that SDD reduced the incidence of ventilator-associated pneumonia (32%).
The majority of individuals had neutral opinions on the risk-benefit profile of SDD (67%), on the benefit in the patients to whom it was delivered (75%), and on whether it reduced mortality (76%).
In the absence of further pediatric-specific trial data, evidence from adult randomized trials that documented a 3.5% reduction in mortality would convince only 34% of respondents to incorporate SDD into their practice. In the absence of further adult randomized trials evidence, 58% of respondents think that performing randomized trials in children is reasonable. Fifty eight percent of respondents think that the results of SDD will be very different in children than in adults.
There was no statistically significant difference in responses by years spent in practice or primary area of practice.
Discussion
In this survey of Canadian providers, SDD was not performed. Compared with recent adult surveys, pediatric providers were less knowledgeable about the evidence base surrounding SDD and were less likely to have strong feelings of opposition or support of the practice [15] . There was concern that SDD may drive antibiotic resistance. Many practitioners wanted to see specific evidence that came from pediatric practice, thinking that the results in a pediatric study will be very Fig. 1 . Selected views about selective digestive decontamination among Canadian providers. different than those in adult studies. No data on why practitioners held this belief was gained from the survey.
These results are unsurprising, given the controversy related to the use of SDD in practice. Despite a strong evidence base, this practice has not been disseminated outside of certain jurisdictions for a variety of reasons, including concerns over driving antibiotic resistance, concerns about the generalizability of the evidence and the lack of pediatric-specific evidence [14, 20, 21] . Because of this, knowledge surrounding SDD is limited, especially among pediatric providers.
Incorporating adult-based evidence into pediatric practice is a controversial subject [22, 23] . As it relates to SDD, the different flora present in the digestive tracts in neonates, compared with adults, may impact the effects of any digestive decontamination protocols [24] . Gut microbiome changes in small children may have long-term effects that would not be relevant to adults [25] . Further, the numbers of critically ill children who are mechanically ventilated for two or more days are relatively small, with the incidence of mortality correspondingly rare; hence, sample size estimates for a large mortality-based trial would be prohibitive, warranting other morbidity-based outcomes [18] . Finally, given the likely lack of mortality benefit and concern for driving resistance, the risk-benefit calculations in children will likely be different than in adults for implementing such an intervention.
This study has some limitations. First, the response rate was relatively low for a survey of this nature, especially among infectious disease physicians; responses among intensive care clinicians were higher, perhaps more reflective of the nature of the intervention. Second, for pragmatic reasons, this survey was designed to be concise and therefore was unable to capture detailed opinions and exploration of the knowledge and opinions among respondents around SDD.
Conclusion
Among pediatric providers in Canada, there was very limited knowledge surrounding selective digestive decontamination, with no institution currently performing it routinely. Most providers would want pediatric-specific data before implementing SDD into their practice. Further research to determine the optimal outcome for such studies, including antibiotic resistance profiles, are warranted, as well as determining the barriers and facilitators to incorporating adult-based evidence on SDD into pediatric practice.
